The SARS-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.
Recombinant SARS-COV-2 Spike S1 protein, His (HEK293), C-His protein is expressed in HEK293 with C-His. It contains the amino acid sequence of 14-685/1273.
Expression System:
HEK293
Reinheit:
> 90% as determined by SDS- PAGE
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten